Key Takeaway
When you use compounded medications) whether it's a GLP-1 for weight management or a peptide like BPC-157 (you have rights. This patient rights compounded medications resource covers the essential information you need to make informed decisions.
When you use compounded medications) whether it's a GLP-1 for weight management or a peptide like BPC-157 (you have rights. This patient rights compounded medications resource covers the essential information you need to make informed decisions. Knowing your patient rights with compounded medications helps you to ask the right questions, demand transparency, and get the safe, quality care you deserve.
Key Takeaways: - Your Right to Information - Your Right to Quality and Safety - Your Right to Provider Access and Follow-Up Care - Your Right to Report Problems
This guide covers what you're entitled to and how to advocate for yourself.
Your Right to Information
You have the right to know what's in your medication and where it comes from. This isn't optional) it's fundamental to informed consent.
Ingredient transparency. You can ask what active and inactive ingredients are in your compounded medication. The pharmacy should be able to tell you the source of the active pharmaceutical ingredient, the inactive ingredients used, and the final concentration.
Pharmacy identification. You have the right to know which pharmacy prepared your medication. This includes the pharmacy's name, address, and license number. With this information, you can verify the pharmacy's standing through your state board of pharmacy.
Testing results. You can request a certificate of analysis (COA) for your medication. This document shows the results of quality testing (potency, sterility, endotoxin levels. A pharmacy that refuses this request should concern you.
Provider credentials. You can verify your prescribing provider's license through your state medical board. You have the right to know their credentials, specialty, and disciplinary history.
"GLP-1 receptor agonists represent the most significant advance in obesity pharmacotherapy in decades. For the first time, we have medications that produce weight loss approaching what was previously only achievable through bariatric surgery.") Dr. Robert Kushner, MD, Northwestern University, speaking at ObesityWeek 2023
Treatment plan details. Your provider should explain why they're prescribing a specific medication, what dose you'll start at, what the expected timeline looks like, and what side effects to watch for. You shouldn't have to guess about your own treatment.
This transparency is standard practice at FormBlends. Learn more about so you can have informed conversations with your provider.
Your Right to Quality and Safety
You deserve medication that meets established quality standards. Here's what that looks like in practice.
USP-compliant preparation. Your compounded medication should be prepared according to United States Pharmacopeia (USP) standards. For injectable medications, this means compliance with USP Chapter 797 for sterile compounding.
Proper labeling. Every compounded medication should be clearly labeled with your name, the drug name and strength, the pharmacy's information, storage instructions, and a beyond-use date. Missing or incomplete labels are unacceptable.
Appropriate packaging. Your medication should arrive in proper pharmaceutical-grade containers, shipped with temperature controls if required. Injectable medications that arrive warm when they should be cold may be compromised.
Verified ingredients. The active pharmaceutical ingredients should come from FDA-registered suppliers. You can ask about ingredient sourcing, and the pharmacy should be forthcoming.
Clean facilities. The pharmacy's compounding facility should meet cleanroom standards for sterile preparations. While you may not visit the facility yourself, you can ask about their cleanroom certifications and inspection history.
If any of these standards aren't met, you have the right to raise concerns with the pharmacy, your provider, and your state board of pharmacy.
Free Download: Compounding Pharmacy Verification Checklist Exercise your rights with confidence. This checklist tells you exactly what to ask and what to look for when evaluating your compounding pharmacy. Get yours free (we'll email it to you instantly. [Email Input] [Download Button]
Your Right to Provider Access and Follow-Up Care
A prescription isn't a one-time transaction. You have the right to ongoing care.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for physician-supervised GLP-1 therapy.
Try the BMI Calculator →Initial evaluation. Before receiving any compounded medication, you should have a thorough clinical evaluation. This includes a review of your medical history, current medications, allergies, and health goals. Your provider should explain the treatment plan and answer your questions.
Ongoing communication. You have the right to reach your provider with questions or concerns about your treatment. This includes questions about side effects, dosing, interactions, and how your treatment is progressing.
Dose adjustments. As your body responds to treatment, your dose may need to change. You have the right to timely dose adjustments based on your progress. Providers shouldn't leave you on an initial dose indefinitely without evaluation.
Second opinions. You always have the right to seek a second opinion from another provider. No legitimate provider or platform will discourage this.
Discontinuation support. If you decide to stop treatment, your provider should guide you through the process safely. Some medications require gradual dose reduction rather than abrupt discontinuation.
FormBlends providers are available for throughout your treatment. You're never on your own.
For information on what to discuss with your provider about side effects, read our .
Your Right to Report Problems
If something goes wrong) or if you suspect something isn't right (you have multiple channels for reporting.
Report to your provider. Your first step should be contacting your prescribing provider about any adverse effects, medication concerns, or quality issues.
Report to the pharmacy. Contact the compounding pharmacy directly if you have concerns about your medication's quality, labeling, or packaging.
State board of pharmacy. File a complaint with the state board of pharmacy that licenses the compounding pharmacy. Most state boards have online complaint forms. They investigate complaints about pharmacy operations, quality issues, and regulatory violations.
State medical board. If your concern is about the prescribing provider's conduct, file a complaint with the state medical board where the provider is licensed.
FDA MedWatch. Report adverse events and quality problems to the FDA's MedWatch program. This helps the FDA identify patterns and take action when needed. You can report online at the FDA's website.
FTC. If a telehealth platform or pharmacy engaged in deceptive marketing, the Federal Trade Commission handles consumer complaints about false advertising and unfair business practices.
You should never feel afraid to report a legitimate concern. Reporting protects other patients and holds providers and pharmacies accountable.
Frequently Asked Questions
Can I choose which compounding pharmacy fills my prescription?
In most cases, yes. You have the right to take your prescription to any licensed compounding pharmacy. However, when using a telehealth platform, the platform may work with specific partner pharmacies. You can ask about this before starting treatment.
Do I have the right to a refund if my medication is defective?
Refund policies vary by pharmacy and platform. If your medication is demonstrably defective) wrong ingredient, failed testing, improper labeling (you should receive a replacement or refund. Document the issue and contact both the pharmacy and your provider.
Can I see my provider's notes about my treatment?
Yes. Under HIPAA, you have the right to access your medical records, including provider notes, prescriptions, and any test results. You can request these from your provider or the platform you used for treatment.
What if my provider won't answer my questions?
A provider who dismisses your questions or refuses to explain your treatment isn't meeting the standard of care. You have the right to switch providers. Consider filing a complaint with the state medical board if the behavior is egregious.
Am I entitled to know if my pharmacy has had enforcement actions?
Yes. Most state boards of pharmacy publish enforcement actions on their websites. You can search by pharmacy name. This information is part of the public record and available to anyone.
Your Personalized Plan Is Waiting
No two patients are the same, and your protocol shouldn't be either. FormBlends providers create customized treatment plans based on your health profile, goals, and preferences.
Sources & References
- Centers for Disease Control and Prevention. Multistate Outbreak of Fungal Meningitis and Other Infections) United States, 2012. MMWR. 2012;61(41):839-842.
- U.S. Food and Drug Administration. Drug Quality and Security Act (DQSA). Public Law 113-54. November 27, 2013.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
- Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
- Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
This article is for educational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider before starting, changing, or stopping any medication or supplement. FormBlends connects you with licensed providers who can evaluate your individual health needs.
Last updated: 2026-03-24